This page contains brief information about copanlisib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Copanlisib hydrochloride is approved to treat:
- Follicular lymphoma that has relapsed. It is used in adults who have received at least two other systemic treatments.
Copanlisib hydrochloride is also being studied in the treatment of other types of cancer.
More About Copanlisib Hydrochloride
Clinical Trials Accepting Patients
Find Clinical Trials for Copanlisib Hydrochloride – Check for trials from TCH’s list of cancer clinical trials now accepting patients.